跳至主要内容
临床试验/NCT05857176
NCT05857176已完成不适用

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines: A Cross-sectional Study.

Damanhour University1 个研究点 分布在 1 个国家目标入组 508 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
508
试验地点
1
主要终点
fatigue incidence

研究概览

简要总结

This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.

详细描述

  • A cross-sectional study was conducted. The subjects participating in the study are residents in Egypt.
  • An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).
  • The questionnaire comprised two categories of inquiries. The first is demographic data of the subject. The second is questions about COVID-19 vaccine-related data, such as whether had taken the vaccine or not, the type of vaccine administered, side effects encountered from the vaccine , if got enough information regarding the vaccine and where obtain the vaccine information from and if reluctant to taking the vaccine and the reasons for hesitancy. All participants were permitted to terminate the survey at any time of the study.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all adults (age ≥ 18 years) complete the questionnaire were considered eligible to participate in the survey.

排除标准

  • Incomplete questionnaires were excluded from the final analysis.

结局指标

主要结局

fatigue incidence

时间窗: 3 month

Pecentage

headache incidence

时间窗: 3 month

Pecentage

fever incidence

时间窗: 3 month

Pecentage

pain at site of injection incidence

时间窗: 3 month

Pecentage

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rehab Werida

Principal Investigator

Damanhour University

研究点 (1)

Loading locations...

相似试验